No Increase in Adverse Events Seen With COVID-19 Vaccination After MIS-C
Minor adverse events seen in 48.6 percent of patients, most often arm soreness and/or fatigue
Minor adverse events seen in 48.6 percent of patients, most often arm soreness and/or fatigue
Early use of steroids in children hospitalized for COVID-19 without MIS-C not associated with shorter length of stay
Pooled analysis of data from phase I and II studies used to evaluate AE of interstitial lung disease/pneumonitis associated with T-Dxd
Incidence of PRAEs reduced with dexmedetomidine versus midazolam among children undergoing tonsillectomy and adenoidectomy
Amoxicillin unlikely to be clinically effective overall or in specified clinical subgroups in whom antibiotics are commonly prescribed
The study authors identified 32 studies that reported on side effects following e-cigarette use.
Early outcomes of two large observational studies show mixed results for the efficacy of immunomodulation with IVIG, glucocorticoids, or both
HFNO suggested for initial or postextubation management of acute hypoxemic respiratory failure in hospitalized adults
Stabilization of lung function independent of the extent of quantitative radiographic interstitial lung disease or fibrosis at baseline
So far, patient has not had any complications or signs of rejection